Clinical Trials Browser

Phase 2 × Recruiting × talimogene laherparepvec × Clear all

NCT03886311 2025-02-24

TNT

Phase 2 Recruiting

Sarcoma

NCT03842943 2024-05-02

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

Phase 2 Recruiting

Melanoma